The trajectory of Sildenafil presents a intricate picture for shareholders. While the initial introduction generated massive gains, the expiration of its intellectual property protection opened the door to off-brand https://bookmarkingquest.com/story21563948/sildenafil-and-the-pharmaceutical-industry-a-risky-investment